Earnings › Pfizer · Pfizer company page · insider trades
Pfizer earnings
Pfizer (PFE) quarterly revenue, net income and diluted EPS from its SEC filings, the upcoming report date, and links to each earnings release. Last update 2026-10-14.
Pfizer (PFE) will report Third Quarter 2026 results on Tuesday, Nov 3, 2026, Performance Report issued that morning; call 10:00 a.m. EST, according to Pfizer (Business Wire). See all Q3 2026 earnings dates.
Source: Pfizer (Business Wire) · Webcast
Subscribe to Pfizer earnings dates in your calendar app (updates automatically)
Also reporting that week
- Apple · Nov 2, 2026
- Palantir · Nov 2, 2026 (not yet confirmed)
- AMD · Nov 3, 2026
- Arista Networks · Nov 3, 2026
- Allstate · Nov 4, 2026
- CVS Health · Nov 4, 2026
- McKesson Corporation · Nov 4, 2026
- MetLife · Nov 4, 2026
Quarterly results
| Quarter | Revenue | YoY | Net income | YoY | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 ended Jun 28, 2026 | $15.03B | +3% | −$248.0M | −109% | −$0.04 |
| Q1 2026 ended Mar 29, 2026 | $14.45B | +5% | $2.69B | −9% | $0.47 |
| Q4 2025 ended Dec 31, 2025 · from annual report | $17.56B | −1% | −$1.65B | −502% | — |
| Q3 2025 ended Sep 28, 2025 | $16.65B | −6% | $3.54B | −21% | $0.62 |
| Q2 2025 ended Jun 29, 2025 | $14.65B | — | $2.91B | — | $0.51 |
| Q1 2025 ended Mar 30, 2025 | $13.71B | — | $2.97B | — | $0.52 |
| Q4 2024 ended Dec 31, 2024 · from annual report | $17.76B | — | $410.0M | — | — |
| Q3 2024 ended Sep 29, 2024 | $17.70B | — | $4.46B | — | $0.78 |
Earnings releases (Form 8-K, Item 2.02)
- Aug 4, 2026: 8-K filing and press release ↗ ·
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
- May 5, 2026: 8-K filing and press release ↗
- Feb 3, 2026: 8-K filing and press release ↗
- Nov 4, 2025: 8-K filing and press release ↗
- Aug 5, 2025: 8-K filing and press release ↗
- Apr 29, 2025: 8-K filing and press release ↗
- Feb 4, 2025: 8-K filing and press release ↗
- Oct 29, 2024: 8-K filing and press release ↗
Source: SEC EDGAR XBRL company facts (10-Q and 10-K) and 8-K filings. Quarters marked "from annual report" are the annual total minus the three reported quarters, because Pfizer reports its fourth quarter only inside the annual report; EPS is not derived for those quarters. Figures are as reported under US GAAP. Not investment advice.
FAQ
Q When is Pfizer's next earnings date?
A Pfizer (PFE) will report Third Quarter 2026 results on Tuesday, Nov 3, 2026, Performance Report issued that morning; call 10:00 a.m. EST, according to Pfizer (Business Wire).
Q What time does Pfizer report earnings?
A Performance Report issued that morning; call 10:00 a.m. EST, per Pfizer (Business Wire).
Q Where can I listen to Pfizer's earnings call?
A Pfizer hosts the webcast on its investor relations site: https://www.pfizer.com/investors
Q What were Pfizer's latest quarterly results?
A For Q2 2026 (ended Jun 28, 2026), Pfizer reported revenue of $15.03B and net income of −$248.0M, or −$0.04 per diluted share, according to its 10-Q filed Aug 4, 2026.